欢迎来到天天文库
浏览记录
ID:49264438
大小:133.15 KB
页数:2页
时间:2020-02-29
《Embosphere联合PVA介入栓塞治疗大咯血45例疗效观察.pdf》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、医学理论与实践2017年第30卷第1期Vol.30,No.1,Jan2017JMedTheor&Prac7Embosphere联合PVA介入栓塞治疗大咯血45例疗效观察林宙李红兰福建省泉州市第一医院影像科362000摘要目的:探讨用Embosphere联合PVA行选择性支气管动脉栓塞术治疗大咯血的效果。方法:45例患者均采用Seldinger法介入栓塞治疗大咯血,选择适当直径的Embosphere及PVA联合栓塞支气管动脉及相关病变血管。结果:45例患者治疗后均完全止血,有效率为100%,随访1~5年3例复发,咯血量和次数均较前明显减少,复发率为6.7%,行再次介入栓塞后均无再
2、咯血;术中2例出现胸痛,术后3例出现发热、咳嗽等症状,经过对症处理后,均在2~4d内缓解,无肢体瘫痪等严重并发症发生。结论:Embosphere联合PVA行选择性支气管动脉栓塞治疗大咯血疗效显著,复发率低,并发症少,是治疗大咯血首选。关键词EmbospherePVA介入栓塞大咯血中图分类号:R452文献标识码:Adoi:10.19381/j.issn.1001-7585.2017.01.003Analysisof45CasesoftheInterventionalEmbolizationbyEmbosphereCombinedwithPVAintheTreatmentofSer
3、iousHemoptysisLINZhou,LIHonglan.DepartmentofRadiology,QuanzhouNo.1Hospital,QuanzhouCity,FujianProvince362000ABSTRACTObjective:ToevaluatetheeffectofEmbospherecombinedwithPVAperforminginterventionalemboliza-tioninserioushemoptysistreatment.Methods:Byusingseldingerinterventionalembolizationinal
4、l45casesserioushe-moptysis,chooseappropriatediameterEmbosphereandPVAcombinedembolizationofbronchialarteryandrelatedleions.Results:Aftertreatmentof45caseswerecompletelystopbleeding,effectiveratewas100%,andwerefollowedupfor1~5years3casesrelapse,hemoptysisquantityandtimesofallthepreviousdecreas
5、edsignificantly,therecur-renceratewas6.7%,lineagain,nolongerhemoptysisafterinterventionalembolization;in2caseswithchestpain,3casesofpostoperativefever,thesymptomsuchascough,aftersymptomatictreatment,allcasesrecoverin2~4days,noparalysisandotherseriouscomplications.Conclusion:Embospherecombine
6、dwithPVAperformingselectivebronchiarteryembolismintheserioushemoptysisasobvioustherapeuticeffect,lowrecurrencerate,lesscomplications,isthepreferredalternativetreatmentforSerioushemoptysis.KEYWORDSEmbosphere,PVA,Embolization,Serioushemoptysis大咯血传统的内科保守治疗及外科手术治疗疗肺血管畸形,7例肺恶性肿瘤。所有患者术前均经[1]。支气管动脉
7、栓效差、创伤大、死亡率及复发率高肺部CT平扫+增强扫描检查确诊,应用止血等药塞术(Bronchialarteryembolization,BAE)是近年物内科治疗无效。来临床治疗大咯血的新方法,具有创伤小、安全、有1.2材料设备器材:GE大型平板DSA,4FCobra[2]。随着介入技术成效、死亡率及复发率低等优点导管、5F动脉鞘、Termo微导管。对比剂:碘佛醇熟及栓塞材料改进,如Embosphere微球、PVA微100ml。栓塞材料:Embosphere微球、PVA颗粒。粒等出现,BAE
此文档下载收益归作者所有